D

10x Genomics, Inc. TXG

$57.07 $0.771.37% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$55.39$58.22
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

TXG Rating

Reward
Risk

TXG Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

TXG Company Overview

10x Genomics, Inc. is a U.S.-based life sciences technology company focused on developing tools and platforms for analyzing biological systems at high resolution. The company operates primarily within the genomics, biotechnology, molecular diagnostics, and life sciences research industries. Its technologies are widely used in single-cell analysis, spatial biology, and immune profiling, supporting applications in academic research, pharmaceutical development, translational medicine, and clinical discovery. Revenue is generated primarily through sales of instruments, consumables, and software services tied to recurring research workflows.

The company’s core business is centered on integrated genomic analysis platforms, including the Chromium, Visium, and Xenium product families. These systems enable researchers to examine gene expression, chromatin accessibility, and cellular interactions with single-cell and spatial resolution. 10x Genomics has built a competitive position through proprietary microfluidics technology, high-throughput sequencing compatibility, and an ecosystem of consumables that generate recurring revenue. Founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness, the company expanded rapidly following the commercialization of its Chromium platform and became publicly traded on Nasdaq in 2019.

Data compiled by narrative technology. May contain errors.
Sector

TXG Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

TXG Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

TXG Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

TXG Price History

Loading...
52-Week Range48% of range
Current
$57.07
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

TXG Valuation

Market Cap
Market Cap Rank
#2,907
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

TXG Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

TXG Corporate Info

Phone Number
925 401 7300
Address
6230 Stoneridge Mall Road
Pleasanton, CA 94588-3260
Country
Year Founded

TXG Filings

Filing Date
Friday, November 6, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 8 and 12 (est)

TXG Headlines